Invention Grant
- Patent Title: Recombinantly produced allergens
- Patent Title (中): 重组产生过敏原
-
Application No.: US13375836Application Date: 2010-06-04
-
Publication No.: US09243045B2Publication Date: 2016-01-26
- Inventor: Lars Mattsson , Jonas Lidholm , Thomas Lundgren
- Applicant: Lars Mattsson , Jonas Lidholm , Thomas Lundgren
- Applicant Address: SE Uppsala
- Assignee: PHADIA AB
- Current Assignee: PHADIA AB
- Current Assignee Address: SE Uppsala
- Agency: Porter, Wright, Morris & Arthur LLP
- Agent Holly Kozlowski
- Priority: SE0950416 20090605
- International Application: PCT/SE2010/050623 WO 20100604
- International Announcement: WO2010/140973 WO 20101209
- Main IPC: C12N1/20
- IPC: C12N1/20 ; C12N5/00 ; C12N5/02 ; C12N15/00 ; C12N15/09 ; C07H21/02 ; C07H21/04 ; A61K39/00 ; C07K1/00 ; C07K14/00 ; C07K17/00 ; G01N33/53 ; C07K14/47 ; G01N33/68
Abstract:
The present invention refers to the field of allergy. More specifically, the invention relates to the identification of new allergens from mammals and to diagnosis and treatment of allergy towards mammals. In particular the invention relates to a recombinantly produced canine allergen, Can f 4, or bovine allergen, Bos d 23k, or variants or fragments thereof sharing epitopes with the wildtype allergen, and the use thereof for the manufacture of a diagnostic composition as well as methods for in vitro diagnosis and treatment of allergy.
Public/Granted literature
- US20120076826A1 Recombinantly Produced Allergens Public/Granted day:2012-03-29
Information query
IPC分类:
